Arkema stock edges higher as half-year 2026 margins hold up

Published on 09/20/2026 at 10:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Arkema stock on Euronext Paris reflected stable pricing around September 18, 2026, backed by revenue growth in the half-year 2026 results. The specialty materials group kept its 2026 guidance in place while shifting earnings further toward higher-margin segments.

Beleuchtete Chemieanlage bei Nacht mit Dampf, Tanks und Rohrleitungen im Industriegebiet — Fotorealistische Chemieanlage bei Dämmerung symbolisiert Arkema S.A. FR0010313833 und industrielle Spezialchemie-Produktion in Frankreich sehr deutlich, Illustration mit AI erstellt.

Arkema stock (ISIN FR0010313833) traded around its recent levels on Euronext Paris as of September 18, 2026, with the price sitting within the 52-week range and supported by revenue growth and disciplined margins in the latest half-year 2026 results. As of September 18, 2026, the market valuation was underpinned by the company’s specialty materials strategy and confirmed guidance for fiscal year 2026, giving investors a clearer view on earnings quality.

Half-year 2026 revenue and margins

According to Arkema’s most recent half-year 2026 results, the group reported consolidated revenue for the period that increased compared with the half-year of 2025, driven by contributions from its advanced materials and coatings segments in specialty materials.

In the same half-year 2026 release, Arkema confirmed its guidance for fiscal year 2026, stating that it continues to expect growth in specialty materials versus 2025 alongside a solid level of EBITDA and free cash flow, signaling confidence in the trajectory of earnings.

Strategic pivot toward specialty materials

Historically, in fiscal year 2023, Arkema’s revenue base and EBITDA had a higher share of intermediate chemicals, whereas the latest half-year 2026 results show a larger proportion of earnings coming from specialty businesses, highlighting a strategic pivot toward higher-margin, less cyclical activities.

For investors, a key takeaway is that in half-year 2026 revenue increased versus half-year 2025 while margins remained disciplined, suggesting that Arkema is managing portfolio shifts without eroding profitability and potentially improving the resilience of cash flows over time.

Stock valuation and trading range

On the market side, Arkema stock’s closing price on Euronext Paris as of September 18, 2026, stood within its 52-week trading corridor rather than at either extreme, indicating that the shares are neither priced as a clear recovery play nor as a distressed story.

This positioning within the 52-week range implies that the market is waiting for further confirmation from upcoming quarters that revenue growth and margin discipline in specialty materials can be sustained, while keeping the valuation supported by the current level of earnings.